Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Dec. 28, 2013	Dec. 29, 2012
Cash flows from operating activities:
Net income	$ 138,475	$ 107,945
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed assets	47,996	43,810
Amortization of intangibles	11,152	11,535
Amortization of deferred financing fees	1,413	1,513
Unrealized loss on foreign currency, net	11,932	2,640
(Gain) loss on disposal of fixed assets	(983)	16
Provision for doubtful accounts	862	668
Provision for sales returns	38,237	44,809
Gain on derivatives, net	(6,830)	(755)
Excess tax benefits from equity-based compensation plans	(4,509)	(2,975)
Deferred income taxes	(33)	2,934
Deferred compensation and stock compensation	7,087	6,165
Other	(225)	363
Changes in assets and liabilities:
Receivables	(99,310)	(115,282)
Inventories	205,602	179,767
Income tax receivable/payable, net	1,185	11,475
Other current assets	(3,443)	(9,635)
Other long-term assets, net	(86)	1,205
Accounts payable and accrued expenses	(71,430)	53,389
Other current liabilities	(5,094)	3,514
Other long-term liabilities	678	(5,959)
Net cash provided by operating activities	272,676	337,142
Cash flows from investing activities:
Change in restricted cash	(537)	3,561
Capital expenditures for fixed assets	(60,822)	(83,458)
Other investing activities	770	100
Net cash used in investing activities	(60,589)	(79,797)
Cash flows from financing activities:
Net change in revolving line of credit		(120,000)
Proceeds from issuance of common stock under compensation plans	1,683	1,127
Repurchase of common stock	(122,464)	(98,530)
Excess tax benefits from equity-based compensation plans	4,509	2,975
Payments on capital lease and financing obligations	(462)	(755)
Repayment of long-term debt	(3,154)	(1,584)
Other financing activities	26	(244)
Net cash used in financing activities	(119,862)	(217,011)
Effect of exchange rate changes on cash and cash equivalents	(3,652)	(98)
Net increase in cash and cash equivalents	88,573	40,236
Cash and cash equivalents at beginning of period	260,092	58,289
Cash and cash equivalents at end of period	348,665	98,525
Supplemental disclosures of cash flow information:
Fixed asset purchases included in accounts payable and not disbursed at the end of each period	21,112	36,770
Noncash investing and financing activities:
Fixed assets acquired under capital lease and financing obligations	12,148	6,607
Settlement of acquisition related liabilities through release of restricted cash		$ 9,227